<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://2medical.news/2026/10/23/oral-vs-parenteral-drug-administration-quantifying-the-future-health-costs-of-routine-prescribing-choices-through-their-environmental-scope/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-10-23T16:00:35+00:00</news:publication_date><news:title>Oral vs parenteral drug administration: Quantifying the future health costs of routine prescribing choices through their environmental scope</news:title><news:keywords>practice</news:keywords></news:news></url><url><loc>https://2medical.news/2026/10/22/the-impact-of-glucagon-like-peptide-1-receptor-agonists-on-risk-of-retinal-vascular-occlusions/</loc><news:news><news:publication><news:name>2 Medical News</news:name><news:language>en-gb</news:language></news:publication><news:publication_date>2026-10-22T07:00:47+00:00</news:publication_date><news:title>The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Risk of Retinal Vascular Occlusions</news:title><news:keywords>Retina, GLP</news:keywords></news:news></url></urlset>